Bee Venom-Loaded Nanoliposomes as an Antioxidant and Erythroprotective Delivery Platform for In Vitro Controlled Release and Improved Gastrointestinal Stability
Authors:
- Perla de Jesús Balcázar-VegaPBPerla de Jesús Balcázar-Vega
- Fridha Viridiana Villalpando-VargasFVFridha Viridiana Villalpando-Vargas
- Paola Viridiana Martínez-BeltránPMPaola Viridiana Martínez-Beltrán
- Silvia Josefina López-PérezSLSilvia Josefina López-Pérez
- Abril Ivett Priscilla Gómez-GuzmánAGAbril Ivett Priscilla Gómez-Guzmán
- Alioth Guerrero-ArandaAlioth Guerrero-Aranda
- Brenda Vega-RuizBVBrenda Vega-Ruiz
- Sofía Dumois-PetersenSDSofía Dumois-Petersen
- Consuelo Ventura-MejíaCVConsuelo Ventura-Mejía
- Ricardo Iván González-VegaRGRicardo Iván González-Vega
Preprint
- 7 September 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Bee venom (BV) contains bioactive peptides with potent antioxidant, anti-inflammatory, and neuroprotective properties, yet its direct therapeutic use is limited by cytotoxicity, instability, and uncontrolled release. This study aimed to develop and evaluate bee venom-loaded nanoliposomes (BV-LN) as an innovative Antioxidant and erythroprotective delivery platform with controlled in vitro release and enhanced gastrointestinal stability for potential applications in neurodegenerative disease management. BV’s antioxidant activity, erythroprotective potential, hemocompatibility, and membrane-stabilizing capacity were systematically assessed, alongside assays for antihemolytic activity against AAPH-induced oxidative hemolysis. BV-LN were synthesized via thin-film hydration and extensively characterized for encapsulation efficiency (84.43 ± 2.26%), water solubility (1.83 µg/mL), centrifugal stability (94.13 ± 3.53%), morphological integrity, and thermal/structural properties (XRD, DSC). Simulated digestion tests confirmed gradual peptide release under gastric and intestinal conditions. Results highlight BV’s strong antioxidant activity (≈70% DPPH inhibition) and marked erythroprotective effects, including >98% hemocompatibility at safe concentrations and significant membrane stabilization under heat and osmotic stress. Encapsulation in nanoliposomes slightly modulated immediate radical scavenging but enhanced safety by preventing excessive hemolysis and enabling controlled melittin release. The robust nanoliposomal structure, driven by peptide–phospholipid hydrophobic anchoring and cholesterol-mediated bilayer ordering, ensured stability under mechanical and digestive stress. This research is highly innovative as it pioneers BV encapsulation for neuroprotective nutraceutical applications, offering a safe, sustained-release platform that could mitigate oxidative stress and inflammation, key drivers of disorders like epilepsy, Alzheimer’s, and Parkinson’s. BV-LN demonstrate strong potential as next-generation carriers for functional foods or therapeutic formulations targeting neurodegenerative diseases, warranting further in vitro validation and translational studies.Keywords
All Related Versions
This publication has 83 references indexed in Scilit:
- Neuroprotective Effects of Melittin Against Cerebral Ischemia and Inflammatory Injury via Upregulation of MCPIP1 to Suppress NF-κB Activation In Vivo and In VitroNeurochemical Research, 2023
- Genetically engineered nano‐melittin vesicles for multimodal synergetic cancer therapyBioengineering & Translational Medicine, 2023
- A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and PatentsBioNanoScience, 2022
- Bee venom acupuncture therapy ameliorates neuroinflammatory alterations in a pilocarpine-induced epilepticus modelMetabolic Brain Disease, 2021
- Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson’s diseaseArchives of Pharmacal Research, 2016
- Carotenes and carotenoids in natural biological samples: a Raman spectroscopic analysisJournal of Raman Spectroscopy, 2009
- Structure and Functions of Channel-Forming Peptides: Magainins, Cecropins, Melittin and AlamethicinThe Journal of Membrane Biology, 1997
- The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP AssayAnalytical Biochemistry, 1996
- In situ resonance Raman spectra of carotenoids in bird's feathersJournal of Raman Spectroscopy, 1995
- K+ channels openers prevent epilepsy induced by the bee venom peptide MCDEuropean Journal of Pharmacology, 1989